Daniel S. Levine

Daniel S. Levine is editor of Rare Daily. You can contact him by sending email to editor@globalgenes.org

Health Canada Scraps Plans for Orphan Drug Framework
Health Canada has derailed a long-fought effort to establish a framework for orphan drugs. Last month the agency, without warning, removed… Continue Reading
Rare Leader: Sharon King
The Basics Name: Sharon King Title: President Organization: Taylor’s Tale Disease focus: CLN1 disease, a form of infantile Batten disease… Continue Reading
Synlogic Reports Positive Results in Early-Stage Study of Treatment for UCD
Rare Daily Staff Synlogic reported positive top-line clinical data from its early-stage trial of experimental therapeutic SYNB1020 as a… Continue Reading
Exonics Raises $40 Million to Advance CRISPR Technology to Treat DMD
Rare Daily Staff Exonics Therapeutics said it completed a series A financing to advance development of its CRISPR technology to repair… Continue Reading
InflaRx Raises $100 Million in IPO
German biopharmaceutical InflaRx, which is developing therapeutics for rare inflammatory diseases, completed a $100 million initial public… Continue Reading
Horama raises $22 million to Advance Gene Therapy Programs for Eye Disease
Rare Daily Staff French biotech Horama, which is developing gene therapies for the treatment of rare, inherited retinal diseases, said it… Continue Reading
The Process of Being Alive
Claire Wineland laughs in the face of death. In fact, she’s made a bit of a career doing this on her own YouTube channel and through… Continue Reading